As shown in Figure 9, we found that SCEP significantly improved the cognitive and memory impairment of the AD mouse model and reduced AD pathology by suppressing HDAC3, in turn increasing the expression of BDNF and NT3 via gut microbiota and SCFAs, suggesting that SCEP can slow down the progression of AD. This evidence concerns the gene HDAC3 and memory impairment.